Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Maciag AE"'
Autor:
D'Ippolito RA; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Rabara D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Blanco MA; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Alberico E; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Drew MR; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Ramakrishnan N; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Sontan D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Widmeyer SRT; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Scheidemantle GM; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Messing S; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Turner D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Arkin M; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143, United States.; Small Molecule Discovery Center, University of California, San Francisco, California 94143, United States., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Stephen AG; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Esposito D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., McCormick F; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94158, United States., Nissley DV; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., DeHart CJ; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2024 Apr 02; Vol. 96 (13), pp. 5223-5231. Date of Electronic Publication: 2024 Mar 18.
Autor:
Sharma AK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: alok.sharma@nih.gov., Pei J; Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA., Yang Y; Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA., Dyba M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Smith B; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Rabara D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Larsen EK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Lightstone FC; Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA., Esposito D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Stephen AG; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Wang B; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA., Beltran PJ; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA., Wallace E; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA., Nissley DV; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., McCormick F; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: anna.maciag@nih.gov.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Feb; Vol. 300 (2), pp. 105650. Date of Electronic Publication: 2024 Jan 16.
Autor:
D'Ippolito RA; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Scheidemantle GM; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rabara D; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Abreu Blanco M; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ramakrishnan N; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Widmeyer SRT; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Messing S; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Turner D; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Maciag AE; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Stephen AG; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Esposito D; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., McCormick F; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Nissley DV; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., DeHart CJ; NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. caroline.dehart@nih.gov.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2823, pp. 291-310.
Autor:
D'Ippolito RA; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Scheidemantle GM; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Smith BP; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Powell K; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Eury S; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Neish A; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mehalko J; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Beaumont L; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fer N; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wall V; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Burgan W; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Esposito D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., DeHart CJ; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. caroline.dehart@nih.gov.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 299-322.
Autor:
Dyba M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. marcin.dyba@nih.gov., Denson JP; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 145-157.
Autor:
Smith BP; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rigby M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ma R; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. anna.maciag@nih.gov.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 271-285.
Autor:
Sharma AK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA. Alok.Sharma@nih.gov.; Leidos Biomedical Research, Inc., Post Office Box B, Frederick, MD, 21702, USA. Alok.Sharma@nih.gov., Dyba M; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA., Tonelli M; National Magnetic Resonance Facility at Madison, Biochemistry Department, University of Wisconsin-Madison, Madison, WI, 53706, USA., Smith B; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA., Gillette WK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA., Esposito D; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA., Nissley DV; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA., McCormick F; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA., Maciag AE; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.
Publikováno v:
Biomolecular NMR assignments [Biomol NMR Assign] 2022 Apr; Vol. 16 (1), pp. 1-8. Date of Electronic Publication: 2021 Oct 22.
Autor:
Kim Y; Chemical Biology Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, United States., Maciag AE; Chemical Biology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States., Cao Z; Chemical Biology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States., Deschamps JR; Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375, United States., Saavedra JE; Chemical Biology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States. Electronic address: saavedjo@mail.nih.gov., Keefer LK; Chemical Biology Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, United States., Holland RJ; Chemical Biology Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, United States. Electronic address: hollandrj@mail.nih.gov.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2015 Aug 01; Vol. 23 (15), pp. 4980-4988. Date of Electronic Publication: 2015 May 19.
Autor:
Maciag AE; Chemical Biology Laboratory, Leidos Biomedical Research, Inc. , Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States., Holland RJ, Kim Y, Kumari V, Luthers CE, Sehareen WS, Biswas D, Morris NL, Ji X, Anderson LM, Saavedra JE, Keefer LK
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2014 Mar 27; Vol. 57 (6), pp. 2292-302. Date of Electronic Publication: 2014 Feb 25.
Autor:
Afonin KA; Center for Cancer Research Nanobiology Program, NCI-Frederick, Frederick, MD 21702, USA, Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA, Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, NCI, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA, HIV Drug Resistance Program, NCI-Frederick, Frederick, MD 21702, USA and Chemical Biology Laboratory, NCI, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Desai R, Viard M, Kireeva ML, Bindewald E, Case CL, Maciag AE, Kasprzak WK, Kim T, Sappe A, Stepler M, Kewalramani VN, Kashlev M, Blumenthal R, Shapiro BA
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2014 Feb; Vol. 42 (3), pp. 2085-97. Date of Electronic Publication: 2013 Nov 04.